The Critical Side Effect Doctors Aren't Discussing: Out-of-Pocket Costs
In this video, I talk about why doctors should talk to patients about out-of-pocket costs when evaluating treatment options.
Similar Posts
Doctor, First Tell Me What It Costs
ByadminIf an antibiotic would cure your infection, your doctor would probably still warn you about the chance of sun sensitivity before prescribing the pill. But even when the costs of a medical intervention might force patients to choose between paying the bill or keeping up with their mortgages, American physicians rarely discuss that serious side effect with…
Gorillacillin and the Tragedy of the Commons
Byadmin
Was I right to prescribe an inferior medication to my patient?
read moreWhere Your Paycheck Is Going
ByadminIf you are wondering why your hourly wage or your salary aren’t rising as quickly as you like, or why your bank account at the end of the year hasn’t grown as much as you intended, don’t forget to take into account just how much more you are probably paying out-of-pocket for the medical care…
Beware of Cancer Metastasizing to Your Wallet
ByadminJoanne Reed’s breast cancer was discovered at an early stage, early enough that her doctors would be able to remove the tumor with surgery (either a mastectomy or a lumpectomy) and then, with a touch of chemo, she would face a decent chance of living out her life without a recurrence. But then Reed’s cancer…
Is Behavioral Economics the Death of Living Wills?
ByadminAs a physician who conducts research on decision-making, I have been asked many times: What does behavioral economics teach us about the role of living wills in medical care? Famed behavioral economist Dick Thaler recently opined on this topic in the New York Times, stating his support for a “requirement that all patients meet with their…
How a Leading Medical Journal Helped a Pharmaceutical Company Exaggerate Medication Benefits
ByadminShutterstock How excited would you be about a medication that lowered your risk of cardiovascular death, heart attack, or stroke by 1.5%? Excited enough to spend a few thousand dollars a year on the drug? I expect not. What if, instead, the drug reduced those same terrible outcomes by 20%? That’s probably enough benefit to…
